This randomized trial will compare the rates of ongoing pregnancy, safety/side effects and acceptability of two medical abortion regimens that are commonly used in Latin America. The first regimen will involve three 800 mcg doses of misoprostol taken buccally in three hour intervals; the second will involve three 800 mcg doses of misoprostol taken sublingually in three hour intervals. This study will also aim to assess the feasibility and acceptability of a semi-quantitative pregnancy test (SQPT) for at-home follow-up in both settings.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
401
Women will receive three 800 mcg doses of misoprostol.
All women will be given a semi-quantitative pregnancy test (SQPT) for at-home follow-up.
Reproductive Health Clinic
La Paz, Pedro Domingo Murillo, Bolivia
Reproductive Health Clinic
Quito, Ecuador
Ongoing pregnancy rates
The study will assess and compare the rates of ongoing pregnancy for the two medical abortion regimens at 1-2 week follow up.
Time frame: 1-2 weeks
Incidence of side effects and complications as a measure of safety/ side effects
Assess and compare the safety/side effects of two regimens of misoprostol alone for early pregnancy termination.
Time frame: 1-2 weeks
Reported acceptability and satisfaction with misoprostol regimen
The study will also assess and compare satisfaction and acceptability of each medical abortion regimen as rated by the women.
Time frame: 1-2 weeks
Usability of SQPT as measured by women's ability to assess success of medical abortion procedure at home
The study will assess women's ability to use the SQPT effectively for at-home assessment of the success of the medical abortion procedure.
Time frame: 1-2 weeks
Self-reported acceptability and satisfaction with SQPT as a means of at-home follow up
The study will also assess the acceptability of the test as a means for at-home follow-up after medical abortion as rated by the women. The woman will answer questions about whether she found the SQPT easy to use an acceptable for at-home follow up.
Time frame: 1-2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.